The point of Cancer Genetics is to distribute top notch logical papers on the cell, hereditary and atomic parts of malignant growth, including disease inclination and clinical symptomatic applications. Explicit territories of intrigue incorporate depictions of new chromosomal, atomic or epigenetic adjustments in benevolent and threatening maladies; novel research facility approaches for recognizable proof and portrayal of chromosomal improvements or genomic modifications in malignant growth cells; connection of hereditary changes with pathology and clinical introduction; and the sub-atomic hereditary qualities of disease inclination. To arrive at an essential science and clinical multidisciplinary crowd, we invite unique full-length articles, surveys, meeting synopses, brief reports, and letters to the editorial manager. Disease investigate has entered another and energizing stage where the combination of data from genomics, bioinformatics and current hereditary qualities are starting to give new insights into how malignancy cells defeat development administrative pathways. To catch this energy, Genes and Cancer covers all parts of the structure and capacity of oncogenes, development silencer and apoptotic qualities, their job in signal transduction and the systems by which their demeanor and capacity are modified during tumor improvement. Notwithstanding distributing original copies that legitimately identify with these territories of research, we would like to pull in papers in the regions of genomics, tranquilize improvement and frameworks science.